Zacks Investment Research
30 Jul 2026, 01:36 UTC · 1h ago
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
30 Jul 2026, 01:36 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Bausch Health (BHC) reported quarterly earnings of $1.26 per share, exceeding the Zacks Consensus Estimate of $0.96 per share by 31.25%. — A significant earnings beat typically provides a short-term positive catalyst for a stock's price.
+0.40Bausch Health reported quarterly revenues of $2.85 billion, surpassing consensus estimates by 7.62%. — Revenue growth and outperformance of estimates signal strong operational demand and top-line health.
+0.30The stock currently holds a Zacks Rank #5 (Strong Sell) due to an unfavorable trend in earnings estimate revisions. — A 'Strong Sell' rating based on downward revisions suggests long-term analyst pessimism despite the immediate quarterly beat.
-0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Despite beating earnings and revenue estimates, the company has a Zacks Rank #5 (Strong Sell) and has underperformed the market significantly this year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Zacks Investment Research
1h ago
